Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Trimeris begins phase I trial of second fusion inhibitor

July 7, 1999

ZymeTx returns anti-HIV compound to Oklahoma Medical Research Foundation

July 6, 1999

New small-molecule HIV protease inhibitors reported

July 6, 1999

Kissei seeks approval of amprenavir in Japan

July 5, 1999

DAPD: another promising agent for combination therapy of HIV/AIDS

July 5, 1999

GW-420867X is a promising component of anti-HIV combination therapy

July 5, 1999

Protease inhibitor BMS-232632, a valuable weapon in the war on AIDS

July 2, 1999

In vitro resistance profile of AG-1776 differs from other protease inhibitors

July 2, 1999

FDA approves new formulation of Abbott's Norvir

July 1, 1999

SJ-3366, a dual inhibitor of HIV reverse transcriptase and viral attachment

July 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.